Differential Diagnosis in a Primary Care Population with Presumed Airway Obstruction: A Real-Life Study

Background: Asthma and chronic obstructive pulmonary disease (COPD) have major symptoms in common. However, the mode of the underlying chronic airway inflammation is different. There is still no single diagnostic test that can be considered a gold standard to distinguish asthma from COPD. Objectives: To determine the diagnostic accuracy for asthma and COPD of a series of diagnostic steps in a population older than 40 years with probable obstructive airway disease (OAD) in primary care. Methods: In this prospective cohort study, patients without a certain diagnosis underwent a work-up, including office spirometry by their general practitioner (GP). They were then referred to a pulmonologist, and they had control visits with their GP. The diagnostic gain of subsequent steps was calculated for 2 endpoints, namely the specialist’s opinion and the GP’s final opinion. Results: Up to 60% of the patients failed to consult with the pulmonologist. For this subgroup, the office spirometry induced significantly more diagnostic congruency than any other diagnostic step. The specialists rejected 44.5% of the diagnoses made by the GPs, including spirometry. High values of diagnostic gain were found after the office spirometry and after the specialist’s advice. Up to 25% of the population taking bronchodilators were judged not to suffer from OAD. Conclusions: Office spirometry added significantly more to the diagnostic certainty of the GPs than questionnaires, history and clinical examination. A pulmonologist’s advice contributed more to diagnostic certainty than any other diagnostic step. Nevertheless, 26% of the diagnoses made by the chest physicians were reconsidered by the GPs.

[1]  J. van der Palen,et al.  Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. , 2002, American journal of respiratory and critical care medicine.

[2]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[3]  R. Djukanović,et al.  Alveolar tissue inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[4]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[5]  F. Martinez Diagnosing chronic obstructive pulmonary disease. The importance of differentiating asthma, emphysema, and chronic bronchitis. , 2015, Postgraduate medicine.

[6]  B. Balbi,et al.  Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[7]  C. van Weel,et al.  A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1. , 1992, The European respiratory journal.

[8]  R. Pauwels,et al.  Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.

[9]  N. Chavannes,et al.  Impact of spirometry on GPs' diagnostic differentiation and decision-making. , 2004, Respiratory medicine.

[10]  D. Price,et al.  Symptom-Based Questionnaire for Differentiating COPD and Asthma , 2006, Respiration.

[11]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[12]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[13]  Ignacio Ibáñez Fernández,et al.  Desarrollo y resultados de un programa de cribado de la EPOC en atención primaria. El proyecto PADOC , 2000 .

[14]  M. Kleerekoper Diagnosing chronic obstructive pulmonary disease. The importance of differentiating asthma, emphysema, and chronic bronchitis. , 1998 .

[15]  S. Ward,et al.  Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation. , 2007, Health technology assessment.

[16]  S. Rennard Treatment of stable chronic obstructive pulmonary disease , 2004, The Lancet.

[17]  C. Donner,et al.  A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. , 2006, Chest.

[18]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[19]  G. J. van der Wilt,et al.  The optimization of the diagnostic work-up in patients with suspected obstructive lung disease , 2010, BMC pulmonary medicine.

[20]  P. Barnes,et al.  Parameters associated with persistent airflow obstruction in chronic severe asthma , 2004, European Respiratory Journal.

[21]  L. Davies,et al.  Effect of primary-care spirometry on the diagnosis and management of COPD , 2006, European Respiratory Journal.

[22]  L. Sichletidis,et al.  The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.

[23]  F. Rengo,et al.  Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. , 2003, Chest.

[24]  N. Thomson,et al.  Asthma and cigarette smoking , 2004, European Respiratory Journal.

[25]  S. Aaron,et al.  Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. , 2006, Chest.

[26]  M. Decramer,et al.  Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT® trial , 2010, European Respiratory Journal.

[27]  D. Price,et al.  Misdiagnosis of COPD and Asthma in Primary Care Patients 40 Years of Age and Over , 2006, The Journal of asthma : official journal of the Association for the Care of Asthma.

[28]  D. Price,et al.  Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997–2001 , 2006, International journal of chronic obstructive pulmonary disease.

[29]  J. Wedzicha,et al.  Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice. , 1999, Respiratory medicine.

[30]  M. Decramer,et al.  Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. , 2010, Respiratory medicine.

[31]  G. Liistro,et al.  Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study. , 2008, Primary care respiratory journal : journal of the General Practice Airways Group.

[32]  J. Bousquet,et al.  Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.

[33]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[34]  P. Bossuyt,et al.  Evaluation of diagnostic tests when there is no gold standard. A review of methods. , 2007, Health technology assessment.

[35]  D. Postma,et al.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. , 1992, Thorax.

[36]  M. Miravitlles,et al.  [Development and results of a screening program for COPD in primary care. The PADOC Project(Program for the Increase in the Diagnosis of COPD in Primary Care]. , 2000, Archivos de bronconeumologia.

[37]  S. Sullivan,et al.  Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease , 2005, Thorax.

[38]  A. Morice,et al.  Difficulties in the Interpretation of Lung Function Tests in the Diagnosis of Asthma and Chronic Obstructive Pulmonary Disease , 2006, The Journal of asthma : official journal of the Association for the Care of Asthma.

[39]  S. Kalra,et al.  EFFECT OF PRIMARY-CARE SPIROMETRY ON THE DIAGNOSIS AND MANAGEMENT OF COPD , 2007 .

[40]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[41]  B. Yawn,et al.  Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. , 2007, Chest.

[42]  V. Backer,et al.  Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. , 1999, The European respiratory journal.

[43]  P. Chanez,et al.  Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? , 2004, Thorax.

[44]  C. Bengtsson,et al.  How often is the diagnosis bronchial asthma correct? , 1999, Family practice.

[45]  A. Lindberg,et al.  Prevalence of Chronic Obstructive Pulmonary Disease according to BTS, ERS, GOLD and ATS Criteria in Relation to Doctor’s Diagnosis, Symptoms, Age, Gender, and Smoking Habits , 2005, Respiration.

[46]  D. Postma,et al.  Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial , 2005, Thorax.

[47]  E. Wouters,et al.  Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. , 1996 .

[48]  J. West GOLD Executive Summary. , 2013, American journal of respiratory and critical care medicine.

[49]  B. Celli,et al.  The importance of spirometry in COPD and asthma: effect on approach to management. , 2000, Chest.

[50]  S. Kleinert,et al.  COPD—a neglected disease , 2004, The Lancet.